Bardy Diagnostics Stock

bardydx.comHealthcareFounded: 1900Funding to Date: $84.02MM

Bardy Diagnostics is the developer of a heart monitor known as Carnation Ambulatory Monitor (CAM™) that can be worn comfortably and discreetly for up to 14 days.

Enterprise Value (based on primary financings)

Register for Details

For more details on financing and valuation for Bardy Diagnostics, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Bardy Diagnostics.

Register Today
Register for Details

For more details on financing and valuation for Bardy Diagnostics, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Team

Management Team

Gust Bardy MD
Founder, Chief Executive Officer, Chief Medical Officer and Chairman
Mark Querry
Chief Financial Officer
Edward Vertatschitsch Ph.D
Chief Operating Officer
Mark Handfelt
Chief Operating Officer
Jonathan Wu
Director, Marketing
Ken Nelson
Chief Commercial Officer
Alan Levy Ph.D
Executive Director

Board Members

David Tamburri
Garheng Kong MD
HealthQuest Capital
Gerry Brunk
Lumira Ventures
Gust Bardy MD
LaViolette Paul
Rubal Bedi
Ascension Ventures
Rurik Vandevenne
River Cities Capital Funds
Warren Watson

Other companies like Bardy Diagnostics in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$1.33B
Sector
Last Round Est. Valuation
$67.5MM
Sector
Last Round Est. Valuation
$1.4B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$885.01MM
Sector
Last Round Est. Valuation
$8.18B
Sector
Last Round Est. Valuation
$1.65B

News

/PRNewswire/ -- Bardy Diagnostics, Inc., ("BardyDx"), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, including the...
Bardy Diagnostics, a Seattle-based business developing a cardiac monitor and arrhythmia detection device, announced this week it has raised $35.5 million